Chevalier X
Rheumatology Department, Henri Mondor Teaching Hospital, Créteil, France.
Rev Rhum Engl Ed. 1997 Oct;64(10):562-77.
Identification of a biological marker for osteoarthritis is a important research priority. A good biological marker would be sensitive to changes in the severity of cartilage destruction. Data from the literature suggest that hyaluronate and cartilage oligomeric matrix protein are more likely to meet this criterion than keratan sulfate, cytokines, or phospholipase A2. Baseline hyaluronate levels and their increase during the first year of follow-up predicted radiographic changes in knee osteoarthritis, and baseline cartilage oligomeric matrix protein levels predicted radiological changes in hip osteoarthritis. Circulating metalloproteinase levels may also deserve to be investigated. Identification of a single predictive marker is probably an unrealistic goal. Current research is focusing on combinations of several markers capable of providing information on the extent of cartilage degradation and anabolism, on subchrondral bone metabolism, and on reactive changes in the synovial membrane.
确定骨关节炎的生物标志物是一项重要的研究重点。一个好的生物标志物应对软骨破坏严重程度的变化敏感。文献数据表明,与硫酸角质素、细胞因子或磷脂酶A2相比,透明质酸和软骨寡聚基质蛋白更有可能符合这一标准。基线透明质酸水平及其在随访第一年中的升高可预测膝关节骨关节炎的影像学变化,而基线软骨寡聚基质蛋白水平可预测髋关节骨关节炎的放射学变化。循环金属蛋白酶水平或许也值得研究。确定单一的预测标志物可能是一个不切实际的目标。目前的研究集中在几种标志物的组合上,这些标志物能够提供有关软骨降解和合成代谢程度、软骨下骨代谢以及滑膜反应性变化的信息。